Category Archives: News

R&D activities have started

Pleco Therapeutics has initiated a sponsored research program at The University of Texas MD Anderson Cancer Center based upon intellectual property developed at MD Anderson and licensed by Pleco. Despite the ongoing Covid pandemic, Pleco Therapeutics is now taking the next step in developing innovative treatments for leukemia patients. MD Anderson is based in Houston,..

Announcement of non-executive team

Pleco is pleased to announce the appointment of Gerard van Leijenhorst, Debra Ainge and Callum Meikle to the non-executive board of directors. Gerard, Debra and Callum are all senior executives and bring a wealth of international experience in the pharmaceutical industry and in executive coaching and management.

Pleco signs license agreement with MD Anderson

Pleco Therapeutics has signed an agreement whereby Pleco licenses intellectual property developed at The University of Texas MD Anderson Cancer Center with the aim of developing innovative treatments for leukemia patients. MD Anderson is based in Houston, Texas and ranks as one of the world’s most respected centres focused on cancer patient care, research, education..